Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program

AIMS: Sodium glucose co‐transporter 2 (SGLT2) inhibitors reduce several cardiovascular risk factors, including plasma glucose, blood pressure, albuminuria and body weight. Long‐term treatment lowers risks of cardiovascular and renal events. The objective of this post hoc analysis was to determine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohkuma, Toshiaki, Van Gaal, Luc, Shaw, Wayne, Mahaffey, Kenneth W., de Zeeuw, Dick, Matthews, David R., Perkovic, Vlado, Neal, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078821/
https://www.ncbi.nlm.nih.gov/pubmed/31729107
http://dx.doi.org/10.1111/dom.13920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078821/
https://www.ncbi.nlm.nih.gov/pubmed/31729107
http://dx.doi.org/10.1111/dom.13920

Ejemplares similares